Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients

Fig. 4

Prognostic associations in this cohort of sequenced metastatic breast cancer patients. a Overall survival by subtype for all recruited patients (n = 323). b Overall survival of patients based on the mutational burden of 4 mutations (75th percentile) or more (n = 234). c Overall survival of ER + HER2 − patients based on the median mutation number of 4 or more (n = 163 patients). d Table of HR for all patients and all subtypes by mutation number per sample. Patients were excluded if there was incomplete survival information. e Spread of TILs across distant metastatic site (n = 123)

Back to article page